TABLE 4.

Vaccine responses by target straina

StrainNo. of subjects, response % (95% CI)
TrL3-4aTrL3-8aTrL-8nL7-8aL7-8nVAMen
H44-7620, 5.0 (0.1-24.9)17, 17.6 (3.8-43.4)13, 30.8 (9.1-61.4)22, 36.4 (17.2-59.3)19, 31.6 (12.6-56.6)15, 26.7 (7.8-55.1)
NZ98/12420, 5.0 (0.1-24.9)15, 0.0 (0.0-21.8)16, 0.0 (0.0-20.6)22, 9.1 (1.1-29.2)18, 11.1 (1.4-34.7)13, 23.1 (5.0-53.8)
76067620, 0.0 (0.0-16.8)17, 5.9 (0.1-28.7)15, 13.3 (1.7-40.5)22, 4.5 (0.1-22.8)18, 5.6 (0.1-27.3)17, 58.8 (32.9-81.6)
  • a The vaccine response was defined as a ≥4-fold increase from pre- to postvaccination 1 month after the third injection. For study group compositions, see Table 1.